GB Patent

GB1381872A — Pharmaceutical compositions for inhalation

Assigned to Fisons Ltd · Expires 1975-01-29 · 51y expired

What this patent protects

1381872 Compositions for inhalation FISONS Ltd 1 June 1972 [22 June 1971] 29207/71 Heading A5B A pharmaceutical powder composition comprises a mixture of a solid inhalation medicament having an effective particle size, (as defined), in the range 0.01 to 10 microns, and a solid ca…

USPTO Abstract

1381872 Compositions for inhalation FISONS Ltd 1 June 1972 [22 June 1971] 29207/71 Heading A5B A pharmaceutical powder composition comprises a mixture of a solid inhalation medicament having an effective particle size, (as defined), in the range 0.01 to 10 microns, and a solid carrier acceptable in the lungs, having an effective particle size in the range of from 80 to 150 microns. Suitable medicaments include the di-sodium salt of 5, 5'-[(5, 5'-(2-hydroxytrimethylene) dioxy) bis (4-oxo-4H-1-benzopyran-2-yl)] tetrazole, sodium cromoglycate, isoprenaline, ephedrine, adrenaline, theophylline, tetracycline, steroids, enzymes, vitamins, antihistamines, N-acetyl cysteine or its salts, propyliodone, tantalum and paracetamol. The carrier may be coated with a material such as stearic acid or polyvinyl pyrrolidone which may give a sustained release action to the medicament.

Drugs covered by this patent

Patent Metadata

Patent number
GB1381872A
Jurisdiction
GB
Classification
Expires
1975-01-29
Drug substance claim
No
Drug product claim
No
Assignee
Fisons Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.